Buƙatar Gudun Tacewar Gel ta ninka ta 2035: Dabarun Tsabtace Peptide

Hasashen: Bukatar Biyu, Ba Blip ba

Adadin kanun labarai ya fito ne daga nazarin kasuwa wanda ke ƙirƙira kasuwar resin na shirye-shiryen gel tacewa ta duniya a babban adadin adadin girma na shekara-shekara - kusan 7-9% - ta hanyar. 2035, tare da fadi chromatography resins kasuwa index hawa zuwa ga nisa 195 ta 2035 na a 2025 tushe na 100. A aikace-aikace wanda shine ninki biyu na shigar da buƙatar tsarkakewa, mai da hankali a masana'antar halittu da, ƙara, a cikin samar da peptide.

Direbobin ba su da hasashe. Girma yana bin rundunonin gani uku: ƙaddamar da sabbin ƙarfin masana'antar halittu, fadada aikin tantanin halitta da aikin jiyya wanda ya dogara da goge-goge mai girma, da kuma ci gaba da sake zagayowar maye gurbin kayan aikin guduro. Don peptides na musamman, Irin wannan tsarin yana haɓaka ta hanyar ginin GLP-1 da bututun asibiti wanda ke motsa 'yan takarar peptide zuwa masana'antar ƙarshen zamani..

Babu ɗayan waɗannan haɗarin hasashen - an riga an fara aiki. Tambayar ita ce ko dabarun ku na ƙasa ya lissafta ta.

What Downstream Capacity Growth Does to Peptide Purification

Tsabtace peptide ba matsala iri ɗaya ba ce, kuma haɓaka iya aiki ya bayyana hakan. Babban tsoho shine juyawa-lokaci HPLC (Farashin RP-HPLC), falala saboda peptide impurities - truncations, jerin sharewa, samfuran epimerization - yawanci sun bambanta da manufa a cikin hydrophobicity. A sikelin bincike wannan tsoho yana aiki. A sikelin kasuwanci yana aiki, amma mai tsada: prep-LC don rabuwa mai wahala na iya mamaye farashin masana'anta, da acetonitrile da trifluoroacetic acid mobile matakan da yake cinyewa suna haifar da sharar gida mai mahimmanci.

Haɓaka haɓaka ƙarfin ƙarfin da farashi. Lokacin da shirin da ke gudana a ɗaruruwan gram ya ƙaura zuwa ɗaruruwan kilogiram, Ayyukan RP-HPLC yana tsayawa tsayin daka a layi, da abin da ya yi kama da hanyar dogaro da kai shirye-shiryen chromatography sikelin-up fara takura yayin da lokuttan ginshiƙi ke ninkawa, juzu'in ƙarfi hawa, da kuma jirgin tsarkakewa - ba reactor kira - ya zama takura. Rahoton masana'antu a kan kalubale masana'antu peptide a bayyane yake cewa abin da ke aiki a ma'aunin lab yakan gaza a sikelin masana'antu, kuma cewa prep-LC sau da yawa shine kawai zaɓi mai yiwuwa don rarrabuwa mai wahala daidai saboda yana mamaye farashi.

Wannan shine ainihin tashin hankalin da hasashen ke fallasa: masana'antar tana haɓaka ƙarfin sauri fiye da yadda ake gina ingantattun hanyoyin ƙasa. Amsar ba shine watsi da RP-HPLC ba. Shi ne a daina kula da shi a matsayin kawai kayan aiki.

Dabarun Tsabtace Tsabtace-Don-Manufa Peptide A maimakon Hanyar Tsoho ɗaya

Mafi ƙaƙƙarfan motsi da ƙungiyar peptide za ta iya yi shine daidaita sinadarai na rabuwa da kayan da ya fi bambanta manufa da ƙazanta., kuma wannan shine inda dabarar tsarkakewa ta peptide mai dacewa da gaske ta bambanta daga wanda aka saba.. Hanyoyi uku suna rufe yawancin peptides, kuma suna amsa tambayoyi daban-daban:

RP-HPLC ya kasance mafi faɗuwar matakin ƙarshe na ƙarshe don peptides na roba, da EMA jagora game da haɓakawa da kera peptides na roba yana kula da ganewa da tsabta azaman buƙatun waɗanda hanyoyin da yawa dole ne su goyi bayan. Amma mai kaifin aiki mai wayo yana tsara hanyoyi maimakon sabawa ɗaya.

Tsarin tsari mai amfani mai matakai biyu shine kama IEX da gogewar RP: mataki na farko yana kawar da ƙazanta masu yawa da rahusa a babban iko, kuma na biyu yana ba da bayanin martaba na ƙarshe. Gel tacewa yayi daidai inda tambaya ta kasance girman - share aggregates, manyan conjugates, ko ragowar reagents - ba inda kuke buƙatar raba bambance-bambancen peptide guda biyu masu alaƙa ba, inda ikon warwarewa ya ƙare. Lokacin da manufa ta yi tsawo, hydrophobic, ko mai saurin haduwa, tsara tsarin wannan hanyar kafin auna girman gano bakin ciki bayan shekara guda, kuma CDMO tare da hanyoyin tsarkakewa biyu akan rukunin yanar gizon na iya tabbatar da zaɓin a zahiri akan kayan da ke nuna tsarin samar da ku..

Samun Gurowa: Shirya Abubuwan Amfani, Ba Hanyar Kawai ba

Rarraba buƙatun tsarkakewa zuwa ɗimbin masu samarwa yana da sakamakon sarkar samarwa. Masana'antun peptide sun riga sun ba da rahoton rashin ƙarfi a cikin abubuwan da ke sama - Bachem's GLP-1 jagorar masana'anta ya lissafa resins masu ƙarfi da amino acid masu kariya daga cikin mahimman albarkatun ƙasa waɗanda ba za a iya ɗaukan ingantaccen wadatar su ba. Wannan dabarar ta shafi kafofin watsa labarai na chromatographic wanda tsarkakewa kanta ya dogara.

Lokacin da kasuwar guduro mai shiri ta ninka, ƙullun ba wai kawai game da wanda ke gina ginshiƙai ba. Samuwar kafofin watsa labarai, yawa-zuwa-yawan daidaito, guduro rayuwa, da takaddun tsari waɗanda ke goyan bayan ingantaccen tsari duk sun zama abubuwan gating. Zaɓin guduro don babban tsari na nufin tabbatar da samun dogon lokaci na matakin da ake buƙata, ba tare da ɗaukan katalogin na yanzu zai kasance cikin tanadi ba a daidai lokacin jagoran.

Al'ada mai amfani ita ce cancantar abin da ake amfani da shi don tsarkakewa kamar yadda ake amfani da shi da gangan kamar hanyar. Kulle mai ba da guduro na farko da wuri, gina ingantaccen tushe na biyu inda ilimin sunadarai gradient ya ba da izini, da kuma tabbatar da darajar kafofin watsa labaru akan ainihin rabuwa da kuke son aiwatarwa a sikelin - saboda resin da ke warwarewa da kyau a nauyin nazari na iya yin aiki daban da zarar an yi lodi akan ginshiƙin samarwa..

Hasashen Sikeli Wanda Ba Ya Daurewa

Hanya mafi haɗari a cikin aikin peptide na ƙasa shine cewa hanyar da ke aiki a sikelin milligram yana canja wurin kai tsaye.. Bai yi ba, saboda dalilan da cewa ƙarfin haɓaka yana da ƙarin sakamako. Manyan ginshiƙai suna canza halayen lodi, canja wurin taro, da ingancin rabuwa. Yin lodin ginshiƙin samarwa yana ƙasƙantar da ƙuduri, kuma a sikelin da ke tilasta sake ingantawa ko canje-canje zuwa dabarun hada dabarun tsakiyar yakin.

Girman ƙarfin yana ƙara ƙarin haɗari: Bayanan ƙazanta na iya canzawa kamar yadda ma'auni ya canza. Gudun kumburi, hadawa bambance-bambance, zafi-canja wurin gradients, da halayen gefe irin su epimerization da shafewa na iya motsa matakan dangi na samfurori. Jerin sikelin GLP-1 wanda ya nuna tsabta 98% tsafta a cikin haɓakawa na iya gabatar da fa'idar ƙazanta mafi girma akan jirgin ƙasa samarwa, kuma ƙananan asarar tsabta a kan babban tsari shine babban asarar kasuwanci.

Dabi'ar da ke ba da kariya ga wannan ƙayyadaddun ƙa'idar canja wuri ce mai ma'auni tare da wuraren bincike: Riƙe kwararar linzamin kwamfuta da tsayin gado akai-akai yayin zazzage sashin giciye, fassara gradient na nazari zuwa sharuɗɗan shirye-shirye kafin yin cikakken ma'auni, kuma sake tabbatar da tsafta da ƙayyadaddun ainihi a kowane mataki tare da rukunin orthogonal da aka bayyana a ƙasa. Canja wurin hanya ya kamata a kula dashi azaman motsa jiki na tabbatarwa tare da ƙofar bayanai, ba maƙasudin ƙarshe ba.

Gwajin Analytical Orthogonal: Layer Tabbatarwa

Haɓaka ƙarfin haɓaka yana ɗaga hannun jari don hujja da kuma samarwa. Kamar yadda girman tsari ke girma, haka kuma sakamakon da'awar tsaftatacciyar hanya guda ɗaya wacce ta rasa ƙazantar haɗin kai, bambancin caji, jimlar, ko tsarin isomer. Orthogonality shine kariya: haɗe-haɗe da dabaru waɗanda ke raba ta hanyar ka'idodin zahiri masu zaman kansu don haka tabo makaho ɗaya ya rufe ta wani.

Masu gudanarwa sun motsa wannan daga kyakkyawan aiki zuwa fata. Ina Q6B da jagororin synthetic-peptide na EMA duka suna ba da shawarar aƙalla hanyoyi guda biyu don tabbatar da ainihi, girman tushen girman, tushen caji, da rarrabuwar tushen hydrophobicity tare da spectroscopic ko tabbaci na tushen taro. Don ƙungiyar peptide panel mai aiki shine:

• Farashin RP-HPLC don ƙididdige tsaftar chromatographic da warware ƙazantattun tsari na hydrophobic. Samuwar Peptide

• Canje-canje a cikin HPLC don fallasa bambance-bambancen caji waɗanda zasu iya haɗa kai akan RP-HPLC.

• SEC / gel tacewa don gano jimlar, gutsuttsura, da kuma oligomeric jihar.

• Matsakaicin maɗaukakiyar spectrometry (HRMS) don tabbatar da taro na monoisotopic da kuma goyan bayan ainihi akan tsarin ka'idar.

• NMR, don tabbatar da tsari fiye da taro lokacin da jerin ko gyare-gyare suka ba da tabbacin tabbatar da matakin atomatik.

Ƙimar ba ta cikin gudanar da kowane bincike akan kowane abu ba - yana cikin ma'anar ma'anar sakin da panel ɗin da ke tattare da su tare da rufe tambayar ainihi.. Batch mai tsabta akan RP-HPLC amma yana nuna bambancin cajin da ke ɓoye akan IEX, ko jimlar akan SEC, shine ainihin gazawar da sakin hanya guda ɗaya zai bari. A cikin kasuwar sikeli inda bayanan mai siyarwar ku ke cikin kunshin tsarin ku, neman cewa shaida ta asali ba na zaɓi ba ne.

Abin da Kungiyoyin Peptide yakamata suyi Yanzu

Hasashen yana ba ku taga tsarawa, kuma yana da kyau a yi amfani da shi da gangan maimakon amsawa. A zahiri:

1. Bincika tsohuwar hanyar ku. Idan kowane peptide a cikin bututun ku ya tafi kai tsaye zuwa RP-HPLC, rubuta bayanin rashin tsarki kowanne a zahiri yana da shi. Inda caji ko bambancin girman shine ainihin mai rarrabawa, gwada matakin IEX ko SEC kuma kwatanta yawan amfanin ƙasa da tsabta.

2. Daidaita guduro tare da hanyar. Tabbatar da samuwa, yawa-zuwa-yawan daidaito, da kuma tsawon rayuwar kafofin watsa labaru kun shirya don daidaitawa - kuma kafa ingantaccen tushe na biyu kafin ku buƙace ta..

3. Ƙayyade wuraren binciken ma'auni. Fassara gradients a cikin nazari zuwa shirye-shirye, riƙe kwararar layi da tsayin gado, kuma sake tabbatar da ƙayyadaddun tsafta tare da ƙofofin bayanai a kowane canja wuri maimakon bayan yaƙin neman zaɓe.

4. Gina kwamiti na sakin orthogonal. Mafi ƙarancin tsaftar RP-HPLC guda biyu tare da hanyar shaida mai zaman kanta kamar HRMS, kuma ƙara IEX ko SEC inda yanayin gazawar kwayoyin ya buƙaci shi, daidaitawa zuwa ICH Q6B da jagororin EMA.

Wannan shine ainihin irin shirin da ƙwararren abokin tarayya peptide ya kamata ya goyi bayan ƙarshe zuwa ƙarshe. CDMO tare da shirye-shiryen HPLC na cikin gida, ma'anar tsarkakewa suites, kuma dakin gwaje-gwaje na orthogonal na iya ɗaukar jeri mai wahala daga yuwuwar milligram ta hanyar masana'antar kilogram tare da hanyar da zaɓin resin da aka yi a gaba - wanda shine inda ƙarfin haɓaka ya ba ku ladan - maimakon gano marigayi.. Canje-canje na MOL yana aiki peptide tsarkakewa da kuma sikelin-up iyawa a cikin irin wannan tsarin aiki, daga Class 100 tsabtace dakin samarwa zuwa gwajin peptide wanda ya haɗa HPLC, MS, da kuma bayanan endotoxin akan kowane tsari.

Kasuwa ta ninka ta 2035 ba abin jira bane. Ƙayyadaddun ƙayyadaddun tsari ne. Ƙungiyoyin da ke kula da tsarkakewa ta ƙasa azaman matsala mai dacewa da manufa ta injiniya - hanya, guduro, girman girman, da kuma shaidar orthogonal yanke shawara tare - za su kasance masu ƙarfin shafi lokacin da kowa ke fafatawa da shi.